Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice. - Wikidata - wikimedia - TriplyDB

Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.

Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.

http://www.wikidata.org/entity/Q37763199

about

Blood pressure control in resistant hypertension: new therapeutic options.Triple combination therapy to improve blood pressure control: experience with olmesartan-amlodipine-hydrochlorothiazide therapy.Olmesartan in the treatment of hypertension in elderly patients: a review of the primary evidence.Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.Clinical management of resistant hypertension: practical recommendations from the Italian Society of Hypertension (SIIA).Strategies to improve control of blood pressure in hypertension: moving towards a 70% objective.Renal artery denervation for treating resistant hypertension : definition of the disease, patient selection and description of the procedure.Diagnosis and treatment of resistant hypertension.

P2860

Q37810910-D9F444D2-BABF-4DC6-8D6B-27B44D25DB36 Q38061463-203F9CFE-0097-4B26-A84F-495E7C1E20DC Q38156340-73D38E5A-E2B5-49DE-BBFB-2812E8C312D9 Q39368546-51DC965E-9C7E-400F-BCE5-DE5E16B5E742 Q45326781-3B60CDC0-0231-4078-9FA1-B7188CEB3190 Q46203356-09EB99B7-BC2B-4716-9D37-B2066DD40AD1 Q51829610-48A0D8C3-5795-4400-AD80-643CF05A204C Q54602151-F7153AA1-A607-4804-BE0B-98779D483AE8

P2860

Challenging hypertension: how to diagnose and treat resistant hypertension in daily clinical practice.

http://www.wikidata.org/entity/Q37763199

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Challenging hypertension: how ...... on in daily clinical practice.

@en

Challenging hypertension: how ...... on in daily clinical practice.

@nl

type

label

Challenging hypertension: how ...... on in daily clinical practice.

@en

Challenging hypertension: how ...... on in daily clinical practice.

@nl

prefLabel

Challenging hypertension: how ...... on in daily clinical practice.

@en

Challenging hypertension: how ...... on in daily clinical practice.

@nl

P1433

Q37763199-6DEAAA05-B0E3-4D2B-A313-2BEA1EAAB16D

P1476

Q37763199-27303806-62E9-4567-A85C-9DF96B73875B

P2093

Q37763199-CA584116-1EF5-46B4-8B84-1DB2C43EF5BD

P2860

Q37763199-06035E94-0F06-4C5C-81E1-6305AC746CC9

Q37763199-09A38D9E-585A-4050-8D58-A68FFFBE54BD

Q37763199-0BA07914-B980-49EB-96B6-B52DB8A13C25

Q37763199-0E9B7763-AB09-489C-84D0-43DD00A51B51

Q37763199-11B26BEF-0166-41D3-884D-A44487DD2855

Q37763199-1324A7B9-78C7-45E3-88A6-BE35B94DD7CC

Q37763199-1AD9D441-CDA4-4BDD-B902-25065F7CCB64

Q37763199-1EB58240-9D1F-4960-A518-87862505A6C8

Q37763199-1F14D586-DAC6-416E-B5B4-B0859DD5DC9F

Q37763199-21834FAF-C071-433A-8B5D-46DAE0AA16F7

P304

Q37763199-8D56B3F5-43D1-4946-99CD-8CDD268B2177

P31

Q37763199-CBCD5B00-AB08-4CAD-A917-90FC357A034A

P356

Q37763199-C9DFF7A0-A04D-4113-BAC6-834240A8CA4E

P433

Q37763199-C533D33E-1879-461C-914C-E744CD795E5A

P478

Q37763199-B3670215-2E4B-4740-9F52-D4147C5F9DC1

P50

Q37763199-4688D0E2-2C0B-4059-AB05-AEFFA7525ABC

Q37763199-BA2DBC23-D48E-404F-8DED-5B54BECB198C

P577

Q37763199-4F85BF4C-8CCB-4279-8ADF-3B3501823561

P5875

Q37763199-51EB4B1B-B804-422E-8E1F-D43F13C00219

P698

Q37763199-DD2BCC36-CFFB-401A-B72E-A2ECB2CC0EE8

P921

Q37763199-563FFB1C-5A07-43D4-A7EF-25AA5186FAA9

P356

P1433

Expert Review of Cardiovascular Therapy

P1476

Challenging hypertension: how ...... ion in daily clinical practice

@en

P2093

Giuliano Tocci

http://www.w3.org/2001/XMLSchema#string

P2860

An international comparative study of blood pressure in populations of European vs. African descent

British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

The challenge of controlling systolic blood pressure: data from the National Health and Nutrition Examination Survey (NHANES III), 1988--1994.

Is resistant hypertension really resistant?

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Hypertension treatment and control in five European countries, Canada, and the United States.

Properly defining white coat hypertension.

Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

P304

811-820

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERC.10.47

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44654470

http://www.w3.org/2001/XMLSchema#string

P698

20528639

http://www.w3.org/2001/XMLSchema#string

P921

arterial hypertension